Failing to publish data from clinical trials presents risk to human health The Science and Technology Committee has expressed concern that nearly half of clinical trials fail to publish their results. The Committee is calling for increased transparency today, as it releases a new Report.
During its inquiry into research integrity earlier this year, the Committee agreed to follow-up on work on ‘clinical trials transparency’ by its predecessor Committee in 2013.
The Research integrity: clinical trials transparency report highlights the work previously done by campaigners, which shows that a shocking 50% of clinical trials do not publish any results, presenting risks to human health and increasing research wastage.
The Committee is concerned that selective non-publication—‘or publication bias'—of results distorts the published evidence base and is a threat to research integrity.
See also:
During its inquiry into research integrity earlier this year, the Committee agreed to follow-up on work on ‘clinical trials transparency’ by its predecessor Committee in 2013.
The Research integrity: clinical trials transparency report highlights the work previously done by campaigners, which shows that a shocking 50% of clinical trials do not publish any results, presenting risks to human health and increasing research wastage.
The Committee is concerned that selective non-publication—‘or publication bias'—of results distorts the published evidence base and is a threat to research integrity.
See also:
No comments:
Post a Comment